[Guide] Supply Chain 101: How to hit the ground running
Kevin Hickman, Senior Manager of Supply Chain Distribution at Gilead sciences shares how those in the early stages of the pharmaceutical supply chain can hit the ground running
Add bookmark
We respect your privacy, by clicking "Download Your Copy" you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest subject to their privacy policy. You have the right to object. In addition, you will receive our e-newsletter, including information on related online learning opportunities. For further information on how we process and monitor your personal data, and information about your privacy and opt-out rights, click here. Download PDF Attachment
In our recent Global State of the Temperature Controlled Pharma Supply Chain survey, 38% of respondents told us they were in the early maturity phase (0-3 years) of their cold chain journey. With the growing number of biotech, therapeutics, cell and gene and innovative drug development companies, this is not surprising.
But for those in this early stage of temperature controlled supply, it can seem like a daunting task.
Discover the key vulnerabilities to counterfeit activity in the supply chain and solutions to improve operational flexibility, build long-term resilience and cut supply chain costs. Download the Report.Pharma Logistics IQ Special Report: Combatting Counterfeit Activity in the Pharma industry
The vendor landscape is complex, the operation challenges are mounting and you are constantly trying to balance a growing number of risks. It’s far from an easy project.
We spoke to Kevin Hickman, Senior Manager of Supply Chain Distribution at Gilead Sciences to hear his advice for how you can achieve cold chain success. With over 20 years of experience in commercial and clinical pharma and biopharma transport management, he understands the key critical success factors you need to know.
In this report, Kevin covers:
With insight from sector experts, learn how to identify weak points in your pharma supply chain and how you can secure them. Download the Pharma Logistics IQ report.“The first step is to acknowledge the problem, and then you can move on to risk management and analysis”
- Why due diligence is a critical part of the process?
- How to leverage the experience of those around you?
- Why you need to fully understand your risk map and tolerance, and,
- How to set yourself up for scalability?
Download your copy now!
